Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moullier

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Human Gene Therapy Methods|May 28, 2016
Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman PrimatesKizito-Tshitoko Tshilenge, Baptiste Ameline, Michel Weber, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|May 17, 2007
Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumF Rolling, Guylène Le Meur, Knut Stieger, et al.
Molecular Therapy. Methods & Clinical Development|September 25, 2023
Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophyCaroline Le Guiner, Xiao Xiao, Thibaut Larcher, et al.
Annals of Neurology|May 24, 2006
Gene therapy of the brain in the dog model of Hurler's syndromeCarine Ciron, Nathalie Desmaris, Marie-Anne Colle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 5, 2013
Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophyElsa Lhériteau, Lolita Petit, Michel Weber, et al.
Chemical Science|June 4, 2021
Chemical modification of the adeno-associated virus capsid to improve gene deliveryMathieu Mével, Mohammed Bouzelha, Aurélien Leray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Human Gene Therapy. Clinical Development|March 12, 2015
Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman PrimatesMichel Zerah, Françoise Piguet, Marie-Anne Colle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal MuscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Scientific Reports|January 23, 2020
Capsid-specific removal of circulating antibodies to adeno-associated virus vectorsBerangere Bertin, Philippe Veron, Christian Leborgne, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Human Gene Therapy Methods|May 28, 2016
Vitrectomy Before Intravitreal Injection of AAV2/2 Vector Promotes Efficient Transduction of Retinal Ganglion Cells in Dogs and Nonhuman PrimatesKizito-Tshitoko Tshilenge, Baptiste Ameline, Michel Weber, et al.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|May 17, 2007
Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumF Rolling, Guylène Le Meur, Knut Stieger, et al.
Molecular Therapy. Methods & Clinical Development|September 25, 2023
Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophyCaroline Le Guiner, Xiao Xiao, Thibaut Larcher, et al.
Annals of Neurology|May 24, 2006
Gene therapy of the brain in the dog model of Hurler's syndromeCarine Ciron, Nathalie Desmaris, Marie-Anne Colle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 5, 2013
Successful gene therapy in the RPGRIP1-deficient dog: a large model of cone-rod dystrophyElsa Lhériteau, Lolita Petit, Michel Weber, et al.
Chemical Science|June 4, 2021
Chemical modification of the adeno-associated virus capsid to improve gene deliveryMathieu Mével, Mohammed Bouzelha, Aurélien Leray, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2008
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Human Gene Therapy. Clinical Development|March 12, 2015
Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman PrimatesMichel Zerah, Françoise Piguet, Marie-Anne Colle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal MuscleAlice Toromanoff, Yan Chérel, Mickaël Guilbaud, et al.
Scientific Reports|January 23, 2020
Capsid-specific removal of circulating antibodies to adeno-associated virus vectorsBerangere Bertin, Philippe Veron, Christian Leborgne, et al.
Pageof 10